Lemtrada hasn’t proven to help against disability in the treatment of relapsing multiple sclerosis, said U.S. advisers who questioned whether the company’s studies were conducted well enough to assess the drug.
While the U.S. Food and Drug Administration advisory panel decided that potential safety risks don’t preclude approval of Lemtrada, its members voted 14-2 that the drug didn’t help improve a patient’s disability. The agency isn’t required to accept the recommendations of its advisers..... Read More - http://www.ms-uk.org/lemtrada
MS drug Lemtrada does not benefit patients, FDA panel says
MS drug Lemtrada does not benefit patients, FDA panel says
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1036 Views
-
Last post by NHE
-
- 0 Replies
- 1137 Views
-
Last post by ElliotB
-
- 0 Replies
- 1736 Views
-
Last post by CureIous
-
- 0 Replies
- 1543 Views
-
Last post by frodo
-
- 0 Replies
- 1543 Views
-
Last post by NHE
-
- 0 Replies
- 1671 Views
-
Last post by NHE
-
- 0 Replies
- 525 Views
-
Last post by NHE
-
- 1 Replies
- 3167 Views
-
Last post by Tif
-
- 0 Replies
- 2455 Views
-
Last post by frodo